|
gptkbp:instanceOf
|
gptkb:cancer
|
|
gptkbp:accountsFor
|
about 40% of lung cancers
|
|
gptkbp:associatedWith
|
gptkb:TP53_mutation
gptkb:ALK_rearrangement
gptkb:EGFR_mutation
gptkb:KRAS_mutation
ROS1 rearrangement
|
|
gptkbp:canMetastasizeTo
|
gptkb:bone
brain
liver
adrenal glands
|
|
gptkbp:commonIn
|
gptkb:women
non-smokers
|
|
gptkbp:diagnosedBy
|
gptkb:CT_scan
biopsy
histopathology
immunohistochemistry
|
|
gptkbp:firstDescribed
|
mid-20th century
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
lung adenocarcinoma
|
|
gptkbp:ICD-10_code
|
C34
|
|
gptkbp:marking
|
gptkb:CK7
gptkb:Napsin_A
gptkb:TTF-1
|
|
gptkbp:mayPresentWith
|
weight loss
cough
shortness of breath
chest pain
hemoptysis
|
|
gptkbp:mostCommonLungCancerType
|
yes
|
|
gptkbp:notMarker
|
gptkb:p63
gptkb:CK20
|
|
gptkbp:originatedIn
|
lung epithelial cells
|
|
gptkbp:prognosis
|
stage at diagnosis
molecular profile
|
|
gptkbp:riskFactor
|
gptkb:air_pollution
smoking
genetic predisposition
asbestos exposure
radon exposure
|
|
gptkbp:subspecies
|
adenocarcinoma in situ
invasive adenocarcinoma
minimally invasive adenocarcinoma
|
|
gptkbp:treatment
|
surgery
radiation therapy
chemotherapy
immunotherapy
targeted therapy
|
|
gptkbp:WHOClassification
|
gptkb:non-small_cell_lung_cancer
|
|
gptkbp:bfsParent
|
gptkb:EGFR_mutation
gptkb:CK7
gptkb:Napsin_A
|
|
gptkbp:bfsLayer
|
5
|